Talent Intelligence Intern at Legend Biotech

Franklin Township, New Jersey, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Biotechnology, HealthcareIndustries

Requirements

Pursuing a Bachelor’s or Master’s degree in HR, Business, Data Analytics, or related field
Strong analytical and research skills
Proficiency in Excel and PowerPoint
Familiarity with LinkedIn or HRIS tools a plus
Excellent communication and attention to detail
Desired Academic Grade Level: Junior; Senior
Preferred Majors: HR, Psychology, Data Science, Business Management

Responsibilities

Conduct research on talent market trends and competitor hiring
Support development of talent dashboards and reports
Analyze internal and external data to identify talent gaps
Assist with quarterly deliverables such as landscape reports and skills gap analyses
Prepare presentations and executive summaries for leadership

Skills

Key technologies and capabilities for this role

ExcelPowerPointData AnalyticsResearchHRISLinkedInData Visualization

Questions & Answers

Common questions about this position

What benefits are offered for this internship?

Legend Biotech offers a best-in-class benefits package including medical, dental, and vision insurance, a 401(k) with company match vesting on day one, equity and stock options for eligible roles, eight weeks of paid parental leave after three months, and a PTO policy with 15 vacation days, 5 personal days, 5 sick days, 11 U.S. holidays, and 3 floating holidays.

Is this internship remote or based in an office?

The role is based in Somerset, NJ, as part of the Talent Acquisition team.

What skills are required for the Talent Intelligence Intern role?

Required skills include strong analytical and research skills, proficiency in Excel and PowerPoint, excellent communication, and attention to detail. Familiarity with LinkedIn or HRIS tools is a plus.

What is the company culture like at Legend Biotech?

Legend Biotech is committed to creating a workplace where employees can thrive professionally and personally, offering a best-in-class benefits package to attract and retain top talent in a competitive industry.

What makes a strong candidate for this internship?

Strong candidates are pursuing a Bachelor’s or Master’s in HR, Business, Data Analytics, or related fields at junior or senior level, with preferred majors in HR, Psychology, Data Science, or Business Management.

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters

2014Year Founded

$146.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.

Collaboration with Multiply Labs may face technological challenges, delaying production timelines.

Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.

The company is technology agnostic, exploring multiple platforms for effective cancer treatments.

Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.

New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.

Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI

Try Jobo Free